Abstract
Bacillus anthracis toxins may be attenuated if macrophages could neutralize toxins upon contact or exposure. Glycoconjugate-bearing polymers, which have been shown to bind to Bacillus spores, were tested for recognition and binding of protective antigen (PA), lethal factor (LF), and edema factor (EF) toxins. We have demonstrated modulation of macrophage activity following exposure to these toxins. Without glycoconjugate (GC) activation, murine macrophages were killed by Bacillus toxins. GCs were shown to have a protective influence, sparing macrophages from toxin-induced cell death, as shown by increased macrophage cell viability based on trypan blue assay. Increased levels of inducible nitric oxide (NO) production by macrophages in presence of GCs suggest that GCs provide an activation signal for macrophages and stimulate their function. Results hint to GCs that promote neutralization of Bacillus toxins, block toxin-induced macrophage death, while increasing macrophage activation. Polymeric GCs may suggest novel approaches to improve existing or develop new vaccines as well as immunotherapeutics.
Similar content being viewed by others
Abbreviations
- Glyc-PAA-flu:
-
Glycoconjugate-polyacrylamide-fluorescein polymer
- GC(s):
-
Glycoconjugate(s)
- GC1:
-
Galα1-3 GalNAcα -PAA-flu
- GC2:
-
Galβ1-3 GalNAcβ-PAA-flu
- GC3:
-
GalNAcα1-3 GalNAcβ -PAA-flu
- GC4:
-
Galβ1-3 Galβ -PAA-flu
- GC5:
-
GlcNAcβ1-4 GlcNAcβ -PAA-flu
- GC6:
-
Fucα1-4 GlcNAcβ -PAA-flu
- GC7:
-
Galβ1-2 Galβ -PAA-flu
- GC8:
-
Fucα1-3 GlcNAcβ -PAA-flu
- GC9:
-
GlcNAcβ1-3 GlcNAcα -PAA-flu
- GC10:
-
GalNAcβ1-6 GalNAcα -PAA-flu
- Gal:
-
Galactose
- GalNAc:
-
N-acetylgalactosamine
- Fuc:
-
Fucose
- GlcNAc:
-
N-acetylglucosamine
- PAA:
-
Polyacrylamide
- Flu:
-
Fluorescein
- LDH:
-
Lactate dehydrogenase
- NO:
-
Nitric oxide
- CFU:
-
Colony forming units
- M:
-
Macrophages
- PA:
-
Protective antigen
- LF:
-
Lethal factor
- EF:
-
Edema factor
- ATR:
-
Anthrax toxin receptor
References
Weiss, M.M., Weiss, P.D., Weiss, J.B.: Anthrax vaccine and public health policy. Am. J. Public Health 97(11), 1945–1951 (2007)
Barnaby, W.: In: Barnaby, W. (ed.) The Plague Markers: The secret World of Biological Warfare. Vision Paperbacks, London (1997)
Jamie, W.E.: Anthrax: diagnosis, treatment, prevention. Prim. Care Update OB/GYNS 9, 117–121 (2002)
Spencer, R.C.: Bacillus anthracis. J. Clin. Pathol. 56, 182–177 (2003)
Friedlander, A.M.: Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261, 7123–7126 (1986)
Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T., Wu, A., Alibek, A., Bailey, C., Alibek, K.: Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527, 211–215 (2002)
Singh, Y., Leppla, S.H., Bhatnagar, R., Friedlander, A.M.: Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. J. Biol. Chem. 264, 11099–11102 (1989)
Cote, C.K., Rossi, C.A., Kang, A.S., Morrow, P.R., Lee, J.S., Welkos, S.L.: The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb. Pathog. 38, 209–225 (2005)
Bradley, K.A., Young, J.A.: Anthrax toxin receptor proteins. Biochem. Pharmacol. 65, 309–314 (2003)
Bonuccelli, G., Sotgia, F., Frank, P.G., Williams, T.M., de Almeida, C.J., Tanowitz, H.B., Sherer, P.E., Hotchkiss, K.A., Terman, B.I., Rollman, B., Alileche, A., Brojatsch, J., Lisanti, M.P.: Anthrax toxin receptor (ATR/TEM8) is highly expressed in epithelial cells lining the toxin’s three sites of entry (lungs, skin, and intestine). Am. J. Physiol. Cell Physiol. 288, C1402–C1410 (2005)
Duesbery, N.S., Vande Woude, G.F.: Anthrax toxins. Cell. Mol. Life. Sci. 55, 1599–1609 (1999)
Guidi-Rontani, C., Mock, M.: Macrophage interactions. Curr. Top. Microbiol. Immunol. 271, 115–141 (2002)
Ramirez, D.M., Leppla, S.H., Schneerson, R., Shiloach, J.: Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J. Ind. Microbiol. Biotechnol. 28, 232–238 (2002)
Little, S.F., Webster, W.M., Ivins, B.E., Fellows, P.F., Norris, S.L., Andrews, G.P.: Development of an in vitro-based potency assay for anthrax vaccine. Vaccine 22, 2843–2852 (2004)
Baillie, L., Read, T.D.: Bacillus anthracis, a bug with attitude! Curr. Opin. Microbiol. 4, 78–81 (2001)
De Bolle, X., Bayliss, C.D., Field, D., van de Ven, T., Saunders, N.J., Hood, D.W., Moxon, E.R.: The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase variation rate of a gene with homology to type III DNA methyltransferases. Mol. Microbiol. 35, 211–222 (2000)
Gabius, H.J., Gabius, S.: Glycosciences: Status and Perspectives. Chapman & Hall, London (1997)
Crocker, P.R., Feizi, T.: Carbohydrate recognition systems: functional trials in cell- cell interaction. Curr. Opin. Struct. Biol. 6, 679–691 (1996)
Feizi, T.: Carbohydrate-mediated recognition systems in innate immunity. Immunol. Rev. 173, 79–88 (2000)
Karlsson, K.A., Angstrom, J., Bergstrom, J., Lanne, B.: Microbial interaction with animal cell surface carbohydrates. APMIS Suppl. 27, 71–83 (1992)
Axford, J.: The impact of glycobiology on medicine. Trends Immunol. 22, 237–239 (2001)
Borman, S.: Carbohydrate vaccines. Chem. Eng. News. 9, 31–35 (2004)
Tarasenko, O., Islam, Sh, Paquiot, D., Levon, K.: Glycoconjugates for recognition of Bacillus spores. Carb. Res. 339, 2859–2870 (2004)
Tarasenko, O., Burton, E., Soderberg, L., Alusta, P.: Polymeric glycoconjugates protect and activate macrophages to promote killing of Bacillus cereus spores during phagocytosis. Glycoconj. J. 25, 473–480 (2008)
Tarasenko, O., Scott, A., Soderberg, S., Ponnappan, U., Alusta, P.: Killing of Bacillus spores is mediated by nitric oxide and nitric oxide synthase during glycoconjugate—enhanced phagocytosis. Glycoconj. J. 27(1), 13–25 (2010)
Tarasenko, O., Soderberg, L., Hester, K., Park Kim, M., McManus, D., Alusta, P.: Glycoconjugates enhanced the intracellular killing of Bacillus spores, increasing macrophage viability and activation. Arch. Microbiol. 189, 579–587 (2008)
Castleberry, J., Alusta, P., Soderberg, L., Tarasenko, O.: Binding and neutralization of Bacillus anthracis protective antigen toxin and its complexes using glycoconjugates. PMSE 98, 841–842 (2008)
Tarasenko O., Alusta P.: Docking approach to study receptor-ligand interactions. In: MidSouth Computational Biology and Bioinformatics Society Fourth Annual Conference. New Orleans, Louisiana, February 1st–3 rd, (abstract/poster) (2007)
Levon K., Tarasenko O., Bin Yu.: Glycoconjugate sensors. U.S. Patent Application Serial No.: 20040161861 (2004)
Keller, R., Geiges, M., Keist, R.: L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res. 50, 1421–1425 (1990)
Beauvais, F., Michel, L., Dubertret, L.: The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett. 361, 229–232 (1995)
Choi, B.M., Pae, H.O., Jang II, S., Kim, Y.M., Chung, H.T.: Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 35, 116–126 (2002)
Dimmelder, S., Haendeler, J., Nehls, M., Zeiher, A.M.: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185, 601–607 (1997)
Kwon, Y.G., Min, J.K., Kim, K.M., Lee, D.J., Billiar, T.R., Kim, Y.M.: Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 276, 10627–10633 (2001)
Vespa, G.N.R., Cunha, F.Q., Silva, J.S.: Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62, 5177–5182 (1994)
Black, J.G.: In: Microbiology: Black J.G. (ed.) Principles and Explorations, pp. 463–484. John Wiley & Sons, Inc. Publishing 2005
Crocker, P.R., Feizi, T.: Carbohydrate recognition systems: functional trials in cell- cell interaction. Curr. Opin. Struct. Biol. 6, 679–691 (1996)
Feizi, T.: Carbohydrate-mediated recognition systems in innate immunity. Immunol. Rev. 173, 79–88 (2000)
Bertozzi, C.R., Kiessling, L.L.: Chemical glycobiology. Science 291, 2357–2364 (2001)
Feizi, T.: Progress in deciphering the information content of the ‘glycome’ - a crescendo in the closing years of the millennium. Glycoconj. J. 17, 553–565 (2000)
Kiessling, L.L., Gestwicki, J.E., Strong, L.E.: Synthetic multivalent ligands in the exploration of cell surface interactions. Curr. Opin. Chem. Biol. 6, 696–703 (2000)
Kiessling, L.L., Pohl, N.L.: Strength in numbers: non-natural polyvalent carbohydrate derivatives. Chem. Biol. 3, 71–77 (1996)
Kojima, N., Hakomori, S.: Sialyllactose-mediated cell Interaction during granulosa cell differentiation. J. Biol. Chem. 264, 20159–20162 (1989)
Kojima, N., Hakomori, S.: Carbohydrate-carbohydrate interaction of glycosphingolipids. J. Biol. Chem. 266, 17552–17558 (1991)
Cunningham, K., Lacy, D.B., Mogridge, J.: Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. PNAS 99(10), 7049–7053 (2002)
Lacy, D.B., Mourez, M., Fouassier, A., Collier, R.J.: Mapping the anthrax protective antigen binding site on the lethal and edema factors. J. Biol. Chem. 277(4), 3006–3010 (2002)
Taylor, M.E.: Recognition of complex carbohydrates by the macrophage mannose receptor. Biochem. Soc. Trans. 21, 468–473 (1993)
Stein, M., Keshav, S., Harris, N., Gordon, S.: Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287–292 (1992)
Stahl, P.D.: The mannose receptor and other macrophage lectins. Curr. Opin. Immunol. 4, 49–52 (1982)
Aderem, A., Underhill, D.M.: Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593–623 (1999)
Rosenberger, C.M., Finlay, B.B.: Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Mol. Cell. Biol. 4, 385–396 (2003)
DeFife, K.M., Jenney, C.R., Colton, E., Anderson, J.M.: Disruption of filamentous actin inhibits human macrophage fusion. FASEB 13, 823–832 (1999)
Acknowledgements
The present study was supported in part by start-up funds and the Kathleen Thomsen Hall Charitable Trust Grant awarded to Tarasenko. This study conforms to the IBC protocol # 09049, the UALR IACUC protocol # R-09-01 and the UAMS IACUC protocol # 2985. The authors extend their appreciation to editors and reviewers, whose comments and suggestions were most helpful in making this manuscript a more solid one for publication in the Glycoconjugate Journal.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarasenko, O., Scott, A., Soderberg, L. et al. Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages. Glycoconj J 29, 25–33 (2012). https://doi.org/10.1007/s10719-011-9360-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-011-9360-3